Abstract
ChIP-seq is the method of choice for profiling protein–DNA interactions, and notably for characterizing the landscape of transcription factor binding and histone modifications. This technique has been widely used to study numerous aspects of tumor biology and led to the development of several promising cancer therapies. In Ewing sarcoma research, ChIP-seq provided important insights into the mechanism of action of the major oncogenic fusion protein EWSR1-FLI1 and related epigenetic and transcriptional changes. In this chapter, we provide a detailed pipeline to analyze ChIP-seq experiments from the preprocessing of raw data to tertiary analysis of detected binding sites. We also advise on best practice to prepare tumor samples prior to sequencing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Audia JE, Campbell RM (2016) Histone modifications and cancer. Cold Spring Harb Perspect Biol 8:a019521
Cosgrove MS, Wolberger C (2005) How does the histone code work? Biochem Cell Biol 83:468–476
Suganuma T, Workman JL (2011) Signals and combinatorial functions of histone modifications. Annu Rev Biochem 80:473–499
Josling GA, Selvarajah SA, Petter M et al (2012) The role of bromodomain proteins in regulating gene expression. Genes (Basel) 3:320–343
Connelly KE, Weaver TM, Alpsoy A et al (2019) Engagement of DNA and H3K27me3 by the CBX8 chromodomain drives chromatin association. Nucleic Acids Res 47:2289–2305
Reiter F, Wienerroither S, Stark A (2017) Combinatorial function of transcription factors and cofactors. Curr Opin Genet Dev 43:73–81
Groth A, Rocha W, Verreault A et al (2007) Chromatin challenges during DNA replication and repair. Cell 128:721–733
Gilmour DS, Lis JT (1984) Detecting protein-DNA interactions in vivo: distribution of RNA polymerase on specific bacterial genes. Proc Natl Acad Sci U S A 81:4275–4279
Gilmour DS, Lis JT (1985) In vivo interactions of RNA polymerase II with genes of Drosophila melanogaster. Mol Cell Biol 5:2009–2018
Solomon MJ, Larsen PL, Varshavsky A (1988) Mapping proteinDNA interactions in vivo with formaldehyde: evidence that histone H4 is retained on a highly transcribed gene. Cell 53:937–947
Beischlag TV, Prefontaine GG, Hankinson O (2018) ChIP-re-ChIP: co-occupancy analysis by sequential chromatin immunoprecipitation. In: Visa N, Jordán-Pla A (eds) Chromatin immunoprecipitation: methods and protocols. Springer, New York, NY, pp 103–112
Zhang J, Dominguez-Sola D, Hussein S et al (2015) Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis. Nat Med 21:1190–1198
Alekseyenko AA, Walsh EM, Wang X et al (2015) The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains. Genes Dev 29:1507–1523
Rui L, Emre NCT, Kruhlak MJ et al (2010) Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell 18:590–605
Boeva V, Louis-Brennetot C, Peltier A et al (2017) Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries. Nat Genet 49:1408–1413
Funato K, Major T, Lewis PW et al (2014) Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science 346:1529–1533
Drelon C, Berthon A, Mathieu M et al (2016) EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression. Hum Mol Genet 25(13):2789–2800
Kim KH, Roberts CWM (2016) Targeting EZH2 in cancer. Nat Med 22:128–134
Kelly AD, Issa J-PJ (2017) The promise of epigenetic therapy: reprogramming the cancer epigenome. Curr Opin Genet Dev 42:68–77
Yashiro-Ohtani Y, Wang H, Zang C et al (2014) Long-range enhancer activity determines Myc sensitivity to notch inhibitors in T cell leukemia. Proc Natl Acad Sci U S A 111:E4946–E4953
Lupiáñez DG, Kraft K, Heinrich V et al (2015) Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions. Cell 161:1012–1025
Braun BS, Frieden R, Lessnick SL et al (1995) Identification of target genes for the Ewing’s sarcoma EWS/FLI fusion protein by representational difference analysis. Mol Cell Biol 15:4623–4630
Sand LGL, Szuhai K, Hogendoorn PCW (2015) Sequencing overview of Ewing sarcoma: a journey across genomic, Epigenomic and transcriptomic landscapes. Int J Mol Sci 16:16176–16215
Kovar H (2010) Downstream EWS/FLI1—upstream Ewing’s sarcoma. Genome Med 2:8
Guillon N, Tirode F, Boeva V et al (2009) The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function. PLoS One 4:e4932
Johnson KM, Taslim C, Saund RS et al (2017) Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma. PLoS One 12:e0186275
Dallmayer M, Li J, Ohmura S et al (2019) Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma. Cell Death Dis 10:1–13
Grünewald TGP, Bernard V, Gilardi-Hebenstreit P et al (2015) Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite. Nat Genet 47:1073–1078
Riggi N, Knoechel B, Gillespie SM et al (2014) EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma. Cancer Cell 26:668–681
Lin L, Huang M, Shi X et al (2019) Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1. Nucleic Acids Res 47:1255–1267
Chaturvedi A, Hoffman LM, Jensen CC et al (2014) Molecular dissection of the mechanism by which EWS/FLI expression compromises actin cytoskeletal integrity and cell adhesion in Ewing sarcoma. Mol Biol Cell 25:2695–2709
Katschnig AM, Kauer MO, Schwentner R et al (2017) EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma. Oncogene 36:5995–6005
Johnson KM, Mahler NR, Saund RS et al (2017) Role for the EWS domain of EWS/FLI in binding GGAA-microsatellites required for Ewing sarcoma anchorage independent growth. Proc Natl Acad Sci U S A 114:9870–9875
Bilke S, Schwentner R, Yang F et al (2013) Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer. Genome Res 23:1797–1809
Harlow ML, Chasse MH, Boguslawski EA et al (2019) Trabectedin inhibits EWS-FLI1 and evicts SWI/SNF from chromatin in a schedule-dependent manner. Clin Cancer Res 25:3417–3429
R Development Core Team (2010) a language and environment for statistical computing: reference index, R Foundation for Statistical Computing, Vienna
Ashoor H, Hérault A, Kamoun A et al (2013) HMCan: a method for detecting chromatin modifications in cancer samples using ChIP-seq data. Bioinformatics 29:2979–2986
Li H, Durbin R (2009) Fast and accurate short read alignment with burrows–wheeler transform. Bioinformatics 25:1754–1760
Li H, Handsaker B, Wysoker A et al (2009) The sequence alignment/map format and SAMtools. Bioinformatics 25:2078–2079
Robinson JT, Thorvaldsdóttir H, Winckler W et al (2011) Integrative genomics viewer. Nat Biotechnol 29:24–26
Ernst J, Kellis M (2012) ChromHMM: automating chromatin-state discovery and characterization. Nat Methods 9:215–216
Amemiya HM, Kundaje A, Boyle AP (2019) The ENCODE Blacklist: Identification of Problematic Regions of the Genome. Sci Rep 9:1–5
Rodríguez-Ubreva J, Ballestar E (2014) Chromatin immunoprecipitation. In: Stockert JC, Espada J, Blázquez-Castro A (eds) Functional analysis of DNA and chromatin. Humana Press, Totowa, NJ, pp 309–318
Wiehle L, Breiling A (2016) Chromatin immunoprecipitation. In: Lanzuolo C, Bodega B (eds) Polycomb group proteins: methods and protocols. Springer, New York, NY, pp 7–21
Wardle FC, Tan H (2015) A ChIP on the shoulder? Chromatin immunoprecipitation and validation strategies for ChIP antibodies. F1000Res 4:235
Egelhofer TA, Minoda A, Klugman S et al (2011) An assessment of histone-modification antibody quality. Nat Struct Mol Biol 18:91–93
Goens G, Rusu D, Bultot L et al (2009) Characterization and quality control of antibodies used in ChIP assays. Methods Mol Biol 567:27–43
Landt SG, Marinov GK, Kundaje A et al (2012) ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res 22:1813–1831
Kinsey M, Smith R, Iyer AK et al (2009) EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing’s sarcoma. Cancer Res 69:9047–9055
Shimizu R, Tanaka M, Tsutsumi S et al (2018) EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma. Cancer Sci 109:2907–2918
Zhang Y, Liu T, Meyer CA et al (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9:R137
Chen Y, Negre N, Li Q et al (2012) Systematic evaluation of factors influencing ChIP-seq fidelity. Nat Methods 9:609–614
Buisine N, Kerdivel G, Sachs LM (2018) De novo transcriptomic approach to study thyroid hormone receptor action in non-mammalian models. In: Plateroti M, Samarut J (eds) Thyroid hormone nuclear receptor: methods and protocols. Springer, New York, NY, pp 265–285
Davis-Turak J, Courtney SM, Hazard ES et al (2017) Genomics pipelines and data integration: challenges and opportunities in the research setting. Expert Rev Mol Diagn 17:225–237
Liang K, Keleş S (2012) Normalization of ChIP-seq data with control. BMC Bioinformatics 13:199
Nair NU, Sahu AD, Bucher P et al (2012) ChIPnorm: a statistical method for normalizing and identifying differential regions in histone modification ChIP-seq libraries. PLoS One 7:e39573
Taslim C, Wu J, Yan P et al (2009) Comparative study on ChIP-seq data: normalization and binding pattern characterization. Bioinformatics 25:2334–2340
Shao Z, Zhang Y, Yuan G-C et al (2012) MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets. Genome Biol 13:R16
Boeva V (2016) Analysis of genomic sequence motifs for deciphering transcription factor binding and transcriptional regulation in eukaryotic cells. Front Genet 7:24
Kulakovskiy IV, Boeva VA, Favorov AV et al (2010) Deep and wide digging for binding motifs in ChIP-Seq data. Bioinformatics 26:2622–2623
McLeay RC, Bailey TL (2010) Motif enrichment analysis: a unified framework and an evaluation on ChIP data. BMC Bioinformatics 11:165
Herrmann C, Van de Sande B, Potier D et al (2012) I-cisTarget: an integrative genomics method for the prediction of regulatory features and cis-regulatory modules. Nucleic Acids Res 40:e114
Heinz S, Benner C, Spann N et al (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38:576–589
Thomas-Chollier M, Sand O, Turatsinze J-V et al (2008) RSAT: regulatory sequence analysis tools. Nucleic Acids Res 36:W119–W127
Yu G, Wang L-G, He Q-Y (2015) ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31:2382–2383
Chen X, Xu H, Yuan P et al (2008) Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133:1106–1117
Zhu LJ, Gazin C, Lawson ND et al (2010) ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics 11:237
Cheng C, Min R, Gerstein M (2011) TIP: a probabilistic method for identifying transcription factor target genes from ChIP-seq binding profiles. Bioinformatics 27:3221–3227
McLean CY, Bristor D, Hiller M et al (2010) GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 28:495–501
Hnisz D, Abraham BJ, Lee TI et al (2013) Super-enhancers in the control of cell identity and disease. Cell 155:934–947
Whyte WA, Orlando DA, Hnisz D et al (2013) Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153:307–319
Lovén J, Hoke HA, Lin CY et al (2013) Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153:320–334
Chapuy B, McKeown MR, Lin CY et al (2013) Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell 24:777–790
Lin CY, Erkek S, Tong Y et al (2016) Active medulloblastoma enhancers reveal subgroup-specific cellular origins. Nature 530:57–62
Saint-André V, Federation AJ, Lin CY et al (2016) Models of human core transcriptional regulatory circuitries. Genome Res 26:385–396
Kong Y (2011) Btrim: a fast, lightweight adapter and quality trimming program for next-generation sequencing technologies. Genomics 98:152–153
Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120
Criscuolo A, Brisse S (2013) AlienTrimmer: a tool to quickly and accurately trim off multiple short contaminant sequences from high-throughput sequencing reads. Genomics 102:500–506
Schubert M, Lindgreen S, Orlando L (2016) AdapterRemoval v2: rapid adapter trimming, identification, and read merging. BMC Res Notes 9:88
Langmead B, Salzberg SL (2012) Fast gapped-read alignment with Bowtie 2. Nat Methods 9:357–359
Dobin A, Davis CA, Schlesinger F et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15–21
Acknowledgments
This work was funded through institutional support from Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, ATIP-Avenir, the ARC Foundation (ARC-RAC16002KSA-R15093KS), the SIRIC CARPEM (No. INCA-DGOS-INSERM_12561), and the “Who Am I?” Laboratory of Excellence ANR-11-LABX-0071, funded by the French Government through its Investissement d′Avenir program, operated by the French National Research Agency (ANR-11-IDEX-0005-02).
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Kerdivel, G., Boeva, V. (2021). Chromatin Immunoprecipitation Followed by Next-Generation Sequencing (ChIP-Seq) Analysis in Ewing Sarcoma. In: Cidre-Aranaz, F., G. P. Grünewald, T. (eds) Ewing Sarcoma . Methods in Molecular Biology, vol 2226. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1020-6_21
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1020-6_21
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1019-0
Online ISBN: 978-1-0716-1020-6
eBook Packages: Springer Protocols